These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11937099)

  • 1. Repeated administration of the neurotensin analogue NT69L induces tolerance to its suppressant effect on conditioned avoidance behaviour.
    Hertel P; Olsen CK; Arnt J
    Eur J Pharmacol; 2002 Mar; 439(1-3):107-11. PubMed ID: 11937099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of tolerance to the suppressant effect of the neurotensin analogue NT69L on amphetamine-induced hyperactivity.
    Hertel P; Byskov L; Didriksen M; Arnt J
    Eur J Pharmacol; 2001 Jun; 422(1-3):77-81. PubMed ID: 11430916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective tolerance to the hypothermic and anticataleptic effects of a neurotensin analog that crosses the blood-brain barrier.
    Boules M; McMahon B; Wang R; Warrington L; Stewart J; Yerbury S; Fauq A; McCormick D; Richelson E
    Brain Res; 2003 Oct; 987(1):39-48. PubMed ID: 14499944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
    Chou S; Davis C; Jones S; Li M
    Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity.
    Boules M; Warrington L; Fauq A; McCormick D; Richelson E
    Eur J Pharmacol; 2001 Aug; 426(1-2):73-6. PubMed ID: 11525773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats.
    Fredrickson P; Boules M; Yerbury S; Richelson E
    Eur J Pharmacol; 2003 Jan; 458(1-2):111-8. PubMed ID: 12498914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic NT69L potently prevents drug-induced disruption of prepulse inhibition without causing tolerance.
    Briody S; Boules M; Oliveros A; Fauq I; Richelson E
    Behav Brain Res; 2010 Feb; 207(1):118-24. PubMed ID: 19800922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
    Shilling PD; Richelson E; Feifel D
    Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
    Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E
    Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly potent neurotensin analog that causes hypothermia and antinociception.
    Tyler-McMahon BM; Stewart JA; Farinas F; McCormick DJ; Richelson E
    Eur J Pharmacol; 2000 Feb; 390(1-2):107-11. PubMed ID: 10708713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurotensin-1 receptor agonist PD149163 inhibits conditioned avoidance responding without producing catalepsy in rats.
    Holly EN; Ebrecht B; Prus AJ
    Eur Neuropsychopharmacol; 2011 Jul; 21(7):526-31. PubMed ID: 21277173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive, hypothermic, hypotensive, and reinforcing effects of a novel neurotensin receptor agonist, NT69L, in rhesus monkeys.
    Fantegrossi WE; Ko MC; Woods JH; Richelson E
    Pharmacol Biochem Behav; 2005 Feb; 80(2):341-9. PubMed ID: 15680187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
    Mechanic JA; Sutton JE; Berson AE; Wu X; Kwan J; Schreiber R; Pang Z; Button DC
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):466-75. PubMed ID: 19223157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
    Prus AJ; Huang M; Li Z; Dai J; Meltzer HY
    Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time course of the antipsychotic effect and the underlying behavioral mechanisms.
    Li M; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2007 Feb; 32(2):263-72. PubMed ID: 16738541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
    Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA
    Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute, but not repeated, administration of the neurotensin NTS1 receptor agonist PD149163 decreases conditioned footshock-induced ultrasonic vocalizations in rats.
    Prus AJ; Hillhouse TM; LaCrosse AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Mar; 49():78-84. PubMed ID: 24275076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
    Feifel D; Melendez G; Murray RJ; Tina Tran DN; Rullan MA; Shilling PD
    Psychopharmacology (Berl); 2008 Oct; 200(2):197-203. PubMed ID: 18568338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurotensin receptor agonist NT69L suppresses sucrose-reinforced operant behavior in the rat.
    Boules M; Iversen I; Oliveros A; Shaw A; Williams K; Robinson J; Fredrickson P; Richelson E
    Brain Res; 2007 Jan; 1127(1):90-8. PubMed ID: 17113052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats.
    Boules M; Oliveros A; Liang Y; Williams K; Shaw A; Robinson J; Fredrickson P; Richelson E
    Neuropeptides; 2011 Feb; 45(1):9-16. PubMed ID: 21047685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.